We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Issues Guidance on Next Generation Sequencing Data for Antiviral Products
CDER Issues Guidance on Next Generation Sequencing Data for Antiviral Products
CDER released final guidance on Thursday on submitting next generation nucleotide sequence (NGS) data to support resistance assessments for antiviral drugs.